Search results

11 results for Mepolizumab

Sorted by Relevance . Sort by Date

  1. Benralizumab for treating severe eosinophilic asthma (TA565)

    Evidence-based recommendations on benralizumab (Fasenra) for treating severe eosinophilic asthma (SEA; elevated levels of eosinophils in blood) in adults

  2. Asthma

    Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart

  3. Technology appraisal block scoping reports

    This information helps ministers to decide whether or not a technology should be formally referred to NICE for appraisal and whether it should be referred as an MTA or an STA.